The pressing challenge for contemporary gene therapy is to deliver enough therapeutic genes to enough cancer cells in vivo. With the aim of improving viral distribution and tumor penetration, we ...
In addition to antigen presentation, successful cancer immunotherapy requires the engagement of the T-cell receptor with an antigen/major histocompatibility complex ...